WAT-to-BAT communication facilitates the sustained activation of BAT thermogenesis during cold exposure
Xue J., Chen D., Wang C., Wang J., Zhou J., Li W.
Laboratory Study, published in Cell Discov (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Cell Discov (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42191682
- PMCID
- PMC13212969
- DOI
- 10.1038/s41421-026-00891-8
Abstract (original English)
The activation of brown adipose tissue (BAT) for thermogenesis represents a crucial physiological mechanism that helps maintain body temperature during cold exposure. Nevertheless, the exact mechanisms underlying the sustained activation of BAT under cold conditions remain incompletely understood. In this study, we reveal that soluble ST2 (sST2) mediates a white adipose tissue (WAT)-to-BAT endocrine mechanism that is essential for the continuous activation of BAT during cold exposure. Specific depletion of sST2 blocks alternative thermogenesis following BAT denervation and renders mice sensitive to cold during prolonged cold exposure. Mechanistically, sST2 is induced and secreted from epididymal white adipose tissue (eWAT) upon the activation of Creb1, which is driven by β1 and β2 adrenergic receptor signaling. Secreted sST2 directly binds to the β3 adrenergic receptor in BAT and, in synergy with norepinephrine, induces BAT thermogenesis independent of IL33. Additionally, supplementation with sST2 promotes beige fat formation. Therefore, our study illustrates a novel mechanism through which the adipokine sST2 derived from eWAT mediates sustained BAT activation during cold exposure through the integration of neural and humoral signals. More importantly, sST2 exerts a synergistic effect on BAT activation when combined with β3-adrenergic receptor agonists.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.